Vigilant Biosciences, Inc. Expands Board of Directors with Esteemed Dental Professional Dr. Linda Niessen

Vigilant Biosciences, Inc. Expands Board of Directors with Esteemed Dental Professional Dr. Linda Niessen June 17, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the expansion of its Board of Directors with the addition of Linda

Vigilant Biosciences Enters Exclusive Agreement with Eurobio for Distribution of OncAlert Oral Cancer Product Line in France, Algeria, Morocco, and Tunisia; Interview with CEO Matthew Kim

Vigilant Biosciences Enters Exclusive Agreement with Eurobio for Distribution of OncAlert Oral Cancer Product Line in France, Algeria, Morocco, and Tunisia; Interview with CEO Matthew Kim June 16, 2015 In what has already been a busy year for Vigilant Biosciences, the Ft. Lauderdale-based maker of early cancer detection products has reached another distribution deal. The

Vigilant Biosciences Signs Marketing Partner for Cancer-Detection System

Vigilant Biosciences Signs Marketing Partner for Cancer-Detection System June 11, 2015 Vigilant Biosciences, a Fort Lauderdale business that develops systems for early detection of cancer, has signed an exclusive sales and marketing partnership with Eurobio. The company will distribute Vigilant’s OncAlert Oral Cancer Risk Assessment System and the and the OncAlert Oral Cancer CD44 +

Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in France, Algeria, Morocco and Tunisia

Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in France, Algeria, Morocco and Tunisia June 10, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive sales and marketing

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev C